Thorlacius, S; Tryggvadottir, L; Olafsdottir, GH; Jonasson, JG; Ogmundsdottir, HM; Tulinius, H; Eyfjord, JE (1995). "Linkage to BRCA2 region in hereditary male breast cancer". Lancet. 346 (8974): 544–5. doi:10.1016/s0140-6736(95)91383-1. PMID7658781. S2CID40129018.
Thorlacius, S; Olafsdottir, G; Tryggvadottir, L; et al. (May 1996). "A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes". Nat. Genet. 13 (1): 117–9. doi:10.1038/ng0596-117. PMID8673089. S2CID8443452.
Sigurdsson, S; Thorlacius, S; Tomasson, J; Tryggvadottir, L; Benediktsdottir, K; Eyfjörd, JE; Jonsson, E (1997). "BRCA2 mutation in Icelandic prostate cancer patients". J Mol Med (Berl). 75 (10): 758–61. doi:10.1007/s001090050162. PMID9383000. S2CID29693378.
Thorlacius, S; Struewing, JP; Hartge, P; Olafsdottir, GH; Sigvaldason, H; Tryggvadottir, L; Wacholder, S; Tulinius, H; Eyfjörd, JE (1998). "Population-based study of risk of breast cancer in carriers of BRCA2 mutation". Lancet. 352 (9137): 1337–9. doi:10.1016/s0140-6736(98)03300-5. PMID9802270. S2CID23584326.
Eyfjord, JE; Bodvarsdottir, SK (2005). "Genomic instability and cancer: networks involved in response to DNA damage". Mutat Res. 592 (1–2): 18–28. doi:10.1016/j.mrfmmm.2005.05.010. PMID16002101.
Bodvarsdottir, SK; Steinarsdottir, M; Bjarnason, H; Eyfjord, JE (2012). "Dysfunctional telomeres in human BRCA2 mutated breast tumors and cell lines". Mutat Res. 729 (1–2): 90–9. doi:10.1016/j.mrfmmm.2011.10.002. PMID22019625.
Thorlacius, S; Tryggvadottir, L; Olafsdottir, GH; Jonasson, JG; Ogmundsdottir, HM; Tulinius, H; Eyfjord, JE (1995). "Linkage to BRCA2 region in hereditary male breast cancer". Lancet. 346 (8974): 544–5. doi:10.1016/s0140-6736(95)91383-1. PMID7658781. S2CID40129018.
Thorlacius, S; Olafsdottir, G; Tryggvadottir, L; et al. (May 1996). "A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes". Nat. Genet. 13 (1): 117–9. doi:10.1038/ng0596-117. PMID8673089. S2CID8443452.
Sigurdsson, S; Thorlacius, S; Tomasson, J; Tryggvadottir, L; Benediktsdottir, K; Eyfjörd, JE; Jonsson, E (1997). "BRCA2 mutation in Icelandic prostate cancer patients". J Mol Med (Berl). 75 (10): 758–61. doi:10.1007/s001090050162. PMID9383000. S2CID29693378.
Thorlacius, S; Struewing, JP; Hartge, P; Olafsdottir, GH; Sigvaldason, H; Tryggvadottir, L; Wacholder, S; Tulinius, H; Eyfjörd, JE (1998). "Population-based study of risk of breast cancer in carriers of BRCA2 mutation". Lancet. 352 (9137): 1337–9. doi:10.1016/s0140-6736(98)03300-5. PMID9802270. S2CID23584326.
Eyfjörd, JE; Thorlacius, S; Steinarsdottir, M; Valgardsdottir, R; Ogmundsdottir, HM; Anamthawat-Jonsson, K (1995). "p53 abnormalities and genomic instability in primary human breast carcinomas". Cancer Res. 55 (3): 646–51. PMID7530599.
Gretarsdottir, S; Thorlacius, S; Valgardsdottir, R; Gudlaugsdottir, S; Sigurdsson, S; Steinarsdottir, M; Jonasson, JG; Anamthawat-Jonsson, K; Eyfjörd, JE (1998). "BRCA2 and p53 mutations in primary breast cancer in relation to genetic instability". Cancer Res. 58 (5): 859–62. PMID9500438.
Eyfjord, JE; Bodvarsdottir, SK (2005). "Genomic instability and cancer: networks involved in response to DNA damage". Mutat Res. 592 (1–2): 18–28. doi:10.1016/j.mrfmmm.2005.05.010. PMID16002101.
Bodvarsdottir, SK; Steinarsdottir, M; Bjarnason, H; Eyfjord, JE (2012). "Dysfunctional telomeres in human BRCA2 mutated breast tumors and cell lines". Mutat Res. 729 (1–2): 90–9. doi:10.1016/j.mrfmmm.2011.10.002. PMID22019625.
Thorlacius, S; Tryggvadottir, L; Olafsdottir, GH; Jonasson, JG; Ogmundsdottir, HM; Tulinius, H; Eyfjord, JE (1995). "Linkage to BRCA2 region in hereditary male breast cancer". Lancet. 346 (8974): 544–5. doi:10.1016/s0140-6736(95)91383-1. PMID7658781. S2CID40129018.
Thorlacius, S; Olafsdottir, G; Tryggvadottir, L; et al. (May 1996). "A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes". Nat. Genet. 13 (1): 117–9. doi:10.1038/ng0596-117. PMID8673089. S2CID8443452.
Sigurdsson, S; Thorlacius, S; Tomasson, J; Tryggvadottir, L; Benediktsdottir, K; Eyfjörd, JE; Jonsson, E (1997). "BRCA2 mutation in Icelandic prostate cancer patients". J Mol Med (Berl). 75 (10): 758–61. doi:10.1007/s001090050162. PMID9383000. S2CID29693378.
Thorlacius, S; Struewing, JP; Hartge, P; Olafsdottir, GH; Sigvaldason, H; Tryggvadottir, L; Wacholder, S; Tulinius, H; Eyfjörd, JE (1998). "Population-based study of risk of breast cancer in carriers of BRCA2 mutation". Lancet. 352 (9137): 1337–9. doi:10.1016/s0140-6736(98)03300-5. PMID9802270. S2CID23584326.